Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing…
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing…
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees…
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical…
Jim Foote, CEO of First Ascent Biomedical, is revolutionizing cancer care with an AI-driven, functional precision medicine platform. Inspired by…
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in…
BOSTON, Sept. 16, 2025 /PRNewswire/ -- Q2i today announced a collaboration with King's College London (King's) to evaluate its AI-powered…
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Haven House Sober Living has been nominated for Best…
Partnership delivers tamper-evident, high-integrity testing data aligned with U.S. Drug Policy Priorities WASHINGTON, Aug. 25, 2025 /PRNewswire/ -- Neopharma Technologies…
Biolabs' CONNECTED DIAGNOSTICS App and decentralized clinical trial platform integrates rapid diagnostic testing, artificial intelligence, and telehealth, all accessible from a smartphone…